← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Gwathmey, Inc.
Cambridge, MA
$16,967,632
Total funding
16
Grants
Funding over time
peak $3.1M · FY2005–09$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$16,967,632 · 16
By mechanism
R44$12,139,622 · 5
R43$3,042,678 · 9
R01$1,506,219 · 1
N43$279,113 · 1
Investigators at Gwathmey, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Optimization of Iron Chelator Delivery System$2,425,024
R44 · FY2008 · HL
Vector Identification and Gene Delivery Approach in Pigs$1,613,011
R44 · FY2006 · HL
Optimization of Iron Chelator Delivery System$1,475,189
R44 · FY2009 · HL
Vector Identification and Gene Delivery Approach in Pigs$1,457,861
R44 · FY2007 · HL
Genes Differentially Expressed During Heart Failure$1,260,000
R44 · FY2004 · HL
Genes Differentially Expressed During Heart Failure$1,230,000
R44 · FY2003 · HL
Animal Model of Ethanol-Induced Cardiomyopathy$970,816
R44 · FY2005 · AA
Animal Model of Ethanol-Induced Cardiomyopathy$826,316
R44 · FY2004 · AA
OPTIMIZATION OF GENE DELIVERY IN ANIMAL HEARTS$706,405
R44 · FY2000 · HL
Molecular Medicine Approaches to the Treatment of Vascular Disease$670,114
R43 · FY2008 · HL
HEART FAILURE--CALCIUM HOMEOSTASIS AND ENERGY RESERVE$473,773
R01 · FY2002 · HL
HEART FAILURE--CALCIUM HOMEOSTASIS AND ENERGY RESERVE$461,830
R01 · FY2001 · HL
HEART FAILURE--CALCIUM HOMEOSTASIS AND ENERGY RESERVE$448,314
R01 · FY2000 · HL
Optimization of Iron Chelator Delivery System$391,500
R43 · FY2001 · HL
RNA Isolation from Heart Samples for Expression Analysis$340,478
R43 · FY2003 · RR
LV Volume Determinations: Mouse to Clinical Applications$286,571
R43 · FY2005 · HL
Animal Model of Ethanol-Induced Cardiomyopathy$279,270
R43 · FY2002 · AA
BIOMEDICAL (APPLIED/EXPLORATORY)$279,113
N43 · FY2009 · HL
TECHNOLOGIES TO IMPROVE THE UTILITY OF ANIMAL MODELS$230,521
R43 · FY2000 · HL
Assessment of a Telemetered PV-ECG System: Murine Models$227,782
R43 · FY2004 · HL